Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder
Part of paid clinical trials in New Orleans, Louisiana.
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Study ID
- NCT07488156
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Psychosis
- Schizoaffective Disorder
- Schizophrenia Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Educational sessions — BEHAVIORALPatients will be given an educational pamphlet with information about schizophrenia spectrum disorders, including prognosis and management options. Following this, they will be allowed to ask the doctor any questions they have pertaining to schizophrenia spectrum disorder. In the second educational session, patients will watch a video containing information about schizophrenia spectrum disorders. Following this, they will be allowed to ask the doctor any questions they have pertaining to this topic.
Study Details
The Impact of Health Literacy on the Attitudes toward Pharmacological Treatment in Patients with Schizophrenia Spectrum Disorder This interventional study is aimed at: * assessing and improving the health literacy and * assessing the attitude towards treatment of patients with schizophrenia spectrum disorders while they are admitted to the inpatient psychiatric unit.
Key Dates
- Start date
- Mar 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Jul 30, 2027
- Completion
- Jan 1, 2028
Study Design
- Enrollment
- 34 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Patients admitted to the inpatient psychiatric unit with a schizophrenia spectrum disorder diagnosisPatients will be exposed to educational materials in the form of a pamphlet and a video
Primary Outcome Measure
Post-intervention KAST (Knowledge About Schizophrenia Test) scores [ Time Frame: This will be collected on Day 5 of the study, after the participant has completed both educational sessions. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Medical Center | New Orleans | Louisiana | 70112 | Jaudé Petrie, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New Orleans, LA
Related Studies
- Database Registry for Neural Network Biomarkers in PsychosisRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as CorrelatesPHASE4 · Recruiting · Corporal Michael J. Crescenz VA Medical Center · Philadelphia, Pennsylvania
- Synbiotic Compound to Reduce Symptoms of SchizophreniaPHASE2 · Recruiting · Sheppard Pratt Health System · Batlimore, Maryland
- Toward a Computationally-Informed, Personalized Treatment for HallucinationsEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut